𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gene expression abnormalities in histologically normal breast epithelium of breast cancer patients

✍ Scribed by Anusri Tripathi; Chialin King; Antonio de la Morenas; Victoria Kristina Perry; Bohdana Burke; Gregory A. Antoine; Erwin F. Hirsch; Maureen Kavanah; Jane Mendez; Michael Stone; Norman P. Gerry; Marc E. Lenburg; Carol L. Rosenberg


Publisher
John Wiley and Sons
Year
2007
Tongue
French
Weight
865 KB
Volume
122
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Normal‐appearing epithelium of cancer patients can harbor occult genetic abnormalities. Data comprehensively comparing gene expression between histologically normal breast epithelium of breast cancer patients and cancer‐free controls are limited. The present study compares global gene expression between these groups. We performed microarrays using RNA from microdissected histologically normal terminal ductal‐lobular units (TDLU) from 2 groups: (i) cancer normal (CN) (TDLUs adjacent to untreated ER+ breast cancers (n = 14)) and (ii) reduction mammoplasty (RM) (TDLUs of age‐matched women without breast disease (n = 15)). Cyber‐T identified differentially expressed genes. Quantitative RT‐PCR (qRT‐PCR), immunohistochemistry (IHC), and comparison to independent microarray data including 6 carcinomas in situ (CIS), validated the results. Gene ontology (GO), UniProt and published literature evaluated gene function. About 127 probesets, corresponding to 105 genes, were differentially expressed between CN and RM (p < 0.0009, corresponding to FDR <0.10). 104/127 (82%) probesets were also differentially expressed between CIS and RM, nearly always (102/104 (98%)) in the same direction as in CN vs. RM. Two‐thirds of the 105 genes were implicated previously in carcinogenesis. Overrepresented functional groups included transcription, G‐protein coupled and chemokine receptor activity, the MAPK cascade and immediate early genes. Most genes in these categories were under‐expressed in CN vs. RM. We conclude that global gene expression abnormalities exist in normal epithelium of breast cancer patients and are also present in early cancers. Thus, cancer‐related pathways may be perturbed in normal epithelium. These abnormalities could be markers of disease risk, occult disease, or the tissue's response to an existing tumor. © 2007 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Systematic characterisation of GABRP exp
✍ Menelaos Zafrakas; Marina Chorovicer; Irima Klaman; Glen Kristiansen; Peter-Joha 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 466 KB

The GABRP gene has been previously identified by in silico analysis of four million ESTs as a candidate gene differentially expressed in breast cancer. GABRP is located on chromosome 5q34 and it encodes the pi-subunit of the gamma-aminobutyric acid (GABA) receptor, a transmembrane protein expressed

Comparison of p53 gene abnormalities in
✍ Takayuki Kinoshita; Masakazu Ueda; Kohji Enomoto; Tadashi Ikeda; Kiyoshi Kikuchi 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 563 KB

Background. The results of recent studies have suggested that p53 gene abnormalities are associated with carcinogenesis in several neoplasms. It is believed that bilateral breast carcinomas develop as a result of a different carcinogenetic mechanism and genetic environment from those of unilateral l

Estrogen alpha and progesterone receptor
✍ Pagona Lagiou; Christina Georgila; Evangelia Samoli; Areti Lagiou; Pantelina Zou 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 62 KB

## Abstract Estrogens play a central role in the etiology of breast cancer, and results from observational studies and randomized trials have also implicated progestins. The effects of these hormones in the mammary tissue are exerted through binding with specific receptor proteins in the cell nucle

Epigenetic silencing of maspin gene expr
✍ Frederick E. Domann; Judd C. Rice; Mary J.C. Hendrix; Bernard W. Futscher 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 135 KB 👁 2 views

Maspin is a tumor suppressor whose expression is lost in many advanced breast cancers. Maspin has been shown to inhibit cell motility, invasion and metastasis; however, its precise role in normal mammary epithelium remains to be elucidated. Although expression of maspin mRNA is low or absent in most

Expression of maspin predicts poor progn
✍ Yoshihisa Umekita; Yasuyo Ohi; Yoshiatsu Sagara; Hiroki Yoshida 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 365 KB

## Abstract The tumor suppressor gene __maspin__ has been reported to inhibit the invasiveness and motility of breast cancer cells. It has been reported that maspin is expressed in normal human mammary epithelial cells but is downregulated during cancer progression, and that p53 could induce maspin